Deoxysugars as antituberculars and alpha-mannosidase inhibitors.

Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis (2004) 3.69

Global tuberculosis drug development pipeline: the need and the reality. Lancet (2010) 2.26

Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinb) (2010) 1.50

Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. Bioorg Med Chem (2010) 1.40

The bittersweet promise of glycobiology. Nat Biotechnol (2001) 1.09

Carbohydrates as scaffolds in drug discovery. ChemMedChem (2006) 1.07

Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate and related compounds. J Med Chem (1987) 1.05

Inactivation of Mycobacterium tuberculosis mannosyltransferase pimB reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death. Glycobiology (2009) 0.94

C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study. J Med Chem (2007) 0.88

Carbohydrate-Based Antibiotics: A New Approach to Tackling the Problem of Resistance. Angew Chem Int Ed Engl (2001) 0.87

Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3. Antiviral Res (2006) 0.86

Studies toward new anti-cancer strategies based on alpha-mannosidase inhibition. Chimia (Aarau) (2010) 0.82

Carbohydrate scaffolds in chemical genetic studies. J Biotechnol (2009) 0.81

The alpha(1,2)-mannosidase I inhibitor 1-deoxymannojirimycin potentiates the antiviral activity of carbohydrate-binding agents against wild-type and mutant HIV-1 strains containing glycan deletions in gp120. FEBS Lett (2007) 0.81

Synthesis and biological evaluation of trans 6-methoxy-1,1-dimethyl-2-phenyl-3-aryl-2,3-dihydro-1H-inden-4-yloxyalkylamine derivatives against drug susceptible, non-replicating M. tuberculosis H37Rv and clinical multidrug resistant strains. Bioorg Med Chem Lett (2013) 0.80

2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies. Eur J Med Chem (2011) 0.79